I think you need to continue your research.
The data on the currently available TAVR valves is not great, some have failed in as little as two years.
By the time DurAVR goes commercial (minimum 2 years imo) there will be pent up demand from cardiologists if our data continues in its current direction, and as they present the ongoing updated data on the podiums.
Your statement regarding brand loyalty is insulting, I’m fairly sure all professionals in this field are looking for the best outcomes for their patients.
I think you need to continue your research.The data on the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |